|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Yang Z, Miao R, Li G, Wu Y, Robson SC,
Yang X, Zhao Y, Zhao H and Zhong Y: Identification of recurrence
related microRNAs in hepatocellular carcinoma after surgical
resection. Int J Mol Sci. 14:1105–1118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J and Sherman M: Management of
hepatocellular carcinoma: an update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wertheim JA, Petrowsky H, Saab S,
Kupiec-Weglinski JW and Busuttil RW: Major challenges limiting
liver transplantation in the United States. Am J Transplant.
11:1773–1784. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Serag HB, Marrero JA, Rudolph L and
Reddy KR: Diagnosis and treatment of hepatocellular carcinoma.
Gastroenterology. 134:1752–1763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yeh JJ and Uemura M: Hepatocellular
carcinoma. N Engl J Med. 366:92author reply 92–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
MacDonald BT, Tamai K and He X:
Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev
Cell. 17:9–26. 2009.
|
|
9
|
Thompson MD and Monga SP: WNT/β-catenin
signaling in liver health and disease. Hepatology. 45:1298–1305.
2007.
|
|
10
|
Clevers H: Wnt/β-catenin signaling in
development and disease. Cell. 127:469–480. 2006.
|
|
11
|
Burke ZD and Tosh D: The Wnt/β-catenin
pathway: master regulator of liver zonation? Bioessays.
28:1072–1077. 2006.
|
|
12
|
Siuta M, Zuckerman SL and Mocco J: Nitric
oxide in cerebral vasospasm: theories, measurement, and treatment.
Neurol Res Int. 2013:9724172013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ozel RE, Alkasir RS, Ray K, Wallace KN and
Andreescu S: Comparative evaluation of intestinal nitric oxide in
embryonic zebrafish exposed to metal oxide nanoparticles. Small.
9:4250–4261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du Q, Zhang X, Cardinal J, Cao Z, Guo Z,
Shao L and Geller DA: Wnt/beta-catenin signaling regulates
cytokine-induced human inducible nitric oxide synthase expression
by inhibiting nuclear factor-kappaB activation in cancer cells.
Cancer Res. 69:3764–3771. 2009. View Article : Google Scholar
|
|
15
|
Bosch FX, Ribes J, Diaz M and Cléries R:
Primary liver cancer: worldwide incidence and trends.
Gastroenterology. 127(Suppl 1): S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hora C, Romanque P and Dufour JF: Effect
of sorafenib on murine liver regeneration. Hepatology. 53:577–586.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pitot HC: Adventures in
hepatocarcinogenesis. Annu Rev Pathol. 2:1–29. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hussain SP, Schwank J, Staib F, Wang XW
and Harris CC: TP53 mutations and hepatocellular carcinoma:
insights into the etiology and pathogenesis of liver cancer.
Oncogene. 26:2166–2176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Willert K and Jones KA: Wnt signaling: is
the party in the nucleus? Genes Dev. 20:1394–1404. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gordon MD and Nusse R: Wnt signaling:
multiple pathways, multiple receptors, and multiple transcription
factors. J Biol Chem. 281:22429–22433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thu KL, Radulovich N, Becker-Santos DD,
Pikor LA, Pusic A, Lockwood WW, Lam WL and Tsao MS: SOX15 is a
candidate tumor suppressor in pancreatic cancer with a potential
role in Wnt/β-catenin signaling. Oncogene. Jan 14–2013.(Epub ahead
of print). View Article : Google Scholar
|
|
22
|
Clements WM, Wang J, Sarnaik A, Kim OJ,
MacDonald J, Fenoglio-Preiser C, Groden J and Lowy AM: β-Catenin
mutation is a frequent cause of Wnt pathway activation in gastric
cancer. Cancer Res. 62:3503–3506. 2002.
|
|
23
|
Li H, Mo J, Jia G, Liu C, Luan Z and Guan
Y: Activation of Wnt signaling inhibits the pro-apoptotic role of
Notch in gastric cancer cells. Mol Med Rep. 7:1751–1756.
2013.PubMed/NCBI
|
|
24
|
Shapiro M, Akiri G, Chin C, Wisnivesky JP,
Beasley MB, Weiser TS, Swanson SJ and Aaronson SA: Wnt pathway
activation predicts increased risk of tumor recurrence in patients
with stage I nonsmall cell lung cancer. Ann Surg. 257:548–554.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lustig B and Behrens J: The Wnt signaling
pathway and its role in tumor development. J Cancer Res Clin Oncol.
129:199–221. 2003.PubMed/NCBI
|
|
26
|
Luo X, Li HX, Liu RX, Wu ZS, Yang YJ and
Yang GS: β-catenin protein utilized by Tumour necrosis factor-alpha
in porcine preadipocytes to suppress differentiation. BMB Rep.
42:338–343. 2009.
|
